216 related articles for article (PubMed ID: 28013363)
1. Bone Structure and Turnover Status in Postmenopausal Women with Atypical Femur Fracture After Prolonged Bisphosphonate Therapy.
Qiu S; Divine GW; Palnitkar S; Kulkarni P; Guthrie TS; Honasoge M; Rao SD
Calcif Tissue Int; 2017 Mar; 100(3):235-243. PubMed ID: 28013363
[TBL] [Abstract][Full Text] [Related]
2. Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.
Qiu S; Dhaliwal R; Divine G; Warner E; Rao SD
J Bone Miner Res; 2024 May; 39(4):417-424. PubMed ID: 38477744
[TBL] [Abstract][Full Text] [Related]
3. Bone Nanomechanical Properties and Relationship to Bone Turnover and Architecture in Patients With Atypical Femur Fractures: A Prospective Nested Case-Control Study.
Griffin LV; Warner E; Palnitkar S; Qiu S; Honasoge M; Griffin SG; Divine G; Rao SD
JBMR Plus; 2021 Sep; 5(9):e10523. PubMed ID: 34532612
[TBL] [Abstract][Full Text] [Related]
4. Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates.
Watts NB; Aggers D; McCarthy EF; Savage T; Martinez S; Patterson R; Carrithers E; Miller PD
J Bone Miner Res; 2017 May; 32(5):1027-1033. PubMed ID: 28071822
[TBL] [Abstract][Full Text] [Related]
5. Influence of bisphosphonate therapy on bone geometry, volumetric bone density and bone strength of femoral shaft in postmenopausal women with rheumatoid arthritis.
Meinen R; Galli-Lysak I; Villiger PM; Aeberli D
BMC Musculoskelet Disord; 2016 Aug; 17():324. PubMed ID: 27491286
[TBL] [Abstract][Full Text] [Related]
6. Bone Formation Parameters of the Biopsied Ilium Differ between Subtrochanteric and Diaphyseal Atypical Femoral Fractures in Bisphosphonate-Treated Patients.
Kondo N; Fukuhara T; Watanabe Y; Miyasaka D; Yamamoto N; Sato H; Wada Y; Nakatsue T; Fujisawa J; Sakuma M; Imai N; Yoda T; Narita I; Endo N
Tohoku J Exp Med; 2017 Dec; 243(4):247-254. PubMed ID: 29212985
[TBL] [Abstract][Full Text] [Related]
7. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
[TBL] [Abstract][Full Text] [Related]
8. Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects.
Tjhia CK; Odvina CV; Rao DS; Stover SM; Wang X; Fyhrie DP
Bone; 2011 Dec; 49(6):1279-89. PubMed ID: 21958843
[TBL] [Abstract][Full Text] [Related]
9. [Atypical femoral fracture and Bisphosphonate.].
Yamamoto N
Clin Calcium; 2017; 27(2):233-238. PubMed ID: 28123125
[TBL] [Abstract][Full Text] [Related]
10. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR
J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
[TBL] [Abstract][Full Text] [Related]
11. [Is SSBT associated with atypical femoral fracture? SSBT is associated with atypical femoral fracture - pathophysiology of atypical femoral fractures - ].
Mashiba T
Clin Calcium; 2012 Jun; 22(6):914-8. PubMed ID: 22653033
[TBL] [Abstract][Full Text] [Related]
12. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy.
Lo JC; Hui RL; Grimsrud CD; Chandra M; Neugebauer RS; Gonzalez JR; Budayr A; Lau G; Ettinger B
Bone; 2016 Apr; 85():142-7. PubMed ID: 26769007
[TBL] [Abstract][Full Text] [Related]
13. Lateral Cortical Thickening and Bone Heterogeneity of the Subtrochanteric Femur Measured With Quantitative CT as Indicators for Early Detection of Atypical Femoral Fractures in Long-Term Bisphosphonate Users.
Lee SH; Lee YH; Suh JS
AJR Am J Roentgenol; 2017 Oct; 209(4):867-873. PubMed ID: 28796551
[TBL] [Abstract][Full Text] [Related]
14. Duration-Dependent Increase of Human Bone Matrix Mineralization in Long-Term Bisphosphonate Users with Atypical Femur Fracture.
Farlay D; Rizzo S; Ste-Marie LG; Michou L; Morin SN; Qiu S; Chavassieux P; Chapurlat RD; Rao SD; Brown JP; Boivin G
J Bone Miner Res; 2021 Jun; 36(6):1031-1041. PubMed ID: 33434290
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.
Miller PD; McCarthy EF
Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241
[TBL] [Abstract][Full Text] [Related]
16. Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure.
Recker RR; Delmas PD; Halse J; Reid IR; Boonen S; García-Hernandez PA; Supronik J; Lewiecki EM; Ochoa L; Miller P; Hu H; Mesenbrink P; Hartl F; Gasser J; Eriksen EF
J Bone Miner Res; 2008 Jan; 23(1):6-16. PubMed ID: 17892374
[TBL] [Abstract][Full Text] [Related]
17. Severely suppressed bone turnover and atypical skeletal fragility.
Visekruna M; Wilson D; McKiernan FE
J Clin Endocrinol Metab; 2008 Aug; 93(8):2948-52. PubMed ID: 18522980
[TBL] [Abstract][Full Text] [Related]
18. Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture.
Tsuchie H; Kasukawa Y; Nozaka K; Kinoshita H; Sasaki K; Aizawa T; Mita M; Ouchi K; Yuasa Y; Miura T; Tomite T; Maekawa S; Abe H; Akagawa M; Shibata N; Fujii M; Takeshima M; Inoue J; Saito H; Miyakoshi N
Med Princ Pract; 2024; 33(1):10-20. PubMed ID: 38104544
[TBL] [Abstract][Full Text] [Related]
19. Study of Atypical Femoral Fracture Cases Coupled in a Multicenter Study.
Zenke Y; Ikeda S; Fukuda F; Tanaka M; Tanaka H; Hirano F; Sakai A
J UOEH; 2016 Sep; 38(3):207-14. PubMed ID: 27627968
[TBL] [Abstract][Full Text] [Related]
20. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
